Back
Y-mAbs Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
84
YMAB
Y-mAbs Therapeutics
Last Price:
15.46
Seasonality Move:
19.38%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and YMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Y-mAbs Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.1 | Buy |
| 20-day SMA: | 14.81 | Buy |
| 50-day SMA: | 14.11 | Buy |
| 200-day SMA: | 13.79 | Buy |
| 8-day EMA: | 15.19 | Buy |
| 20-day EMA: | 14.8 | Buy |
| 50-day EMA: | 14.18 | Buy |
| 200-day EMA: | 12.71 | Buy |
Y-mAbs Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 62.32 | Buy |
| Chaikin Money Flow: | 466556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.21 - 15.11) | Buy |
| Bollinger Bands (100): | (11.83 - 14.47) | Buy |
Y-mAbs Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Y-mAbs Therapeutics Stock
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 15.46 while YMAB 8-day simple moving average is 15.10, which is a Buy signal.
- The stock price of YMAB is 15.46 while Y-mAbs Therapeutics 20-day SMA is 14.81, which makes it a Buy.
- Y-mAbs Therapeutics 50-day simple moving average is 14.11 while YMAB share price is 15.46, making it a Buy technically.
- YMAB stock price is 15.46 and Y-mAbs Therapeutics 200-day simple moving average is 13.79, creating a Buy signal.
YMAB Technical Analysis vs Fundamental Analysis
Buy
84
Y-mAbs Therapeutics (YMAB)
is a Buy
Is Y-mAbs Therapeutics a Buy or a Sell?
-
Y-mAbs Therapeutics stock is rated a Buy
The current Y-mAbs Therapeutics [YMAB] share price is $15.46. The Score for YMAB is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
Y-mAbs Therapeutics Stock Info
Market Cap:
689.05M
Price in USD:
15.46
Share Volume:
540.53K
Y-mAbs Therapeutics 52-Week Range
52-Week High:
20.90
52-Week Low:
4.69
Buy
84
Y-mAbs Therapeutics (YMAB)
is a Buy
Y-mAbs Therapeutics Share Price Forecast
-
What is the Y-mAbs Therapeutics stock price today?
The Y-mAbs Therapeutics stock price is 15.46 USD today. -
Will YMAB stock go up or go down?
Y-mAbs Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Y-mAbs Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Y-mAbs Therapeutics is not overvalued.
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 15.46 while YMAB 8-day exponential moving average is 15.19, which is a Buy signal.
- The stock price of YMAB is 15.46 while Y-mAbs Therapeutics 20-day EMA is 14.80, which makes it a Buy.
- Y-mAbs Therapeutics 50-day exponential moving average is 14.18 while YMAB share price is 15.46, making it a Buy technically.
- YMAB stock price is 15.46 and Y-mAbs Therapeutics 200-day simple moving average is 12.71, creating a Buy signal.
Fundamental Analysis of Y-mAbs Therapeutics
Is Y-mAbs Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.11 per share.
Technical Analysis of Y-mAbs Therapeutics
Should I short Y-mAbs Therapeutics stock?
- YMAB Moving Average Covergence Divergence (MACD) indicator is 0.39, suggesting Y-mAbs Therapeutics is a Buy
- Y-mAbs Therapeutics Relative Strength Index (RSI) is 62.32, which suggest Y-mAbs Therapeutics is overbought
- The Bollinger Bands (25) for Y-mAbs Therapeutics is (14.21 - 15.11), which suggest Y-mAbs Therapeutics is a Buy
- The Bollinger Bands (100) for Y-mAbs Therapeutics is (11.83 - 14.47), which suggest Y-mAbs Therapeutics is a Buy
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.